ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals Inc (KALV)

9,75
0,53
(5,75%)
Fermé 05 Février 10:00PM
9,74
-0,01
( -0,10% )
Avant marché: 10:12AM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
9,74
Prix Achat
7,50
Prix Vente
14,00
Volume échangé
100
0,00 Fourchette du Jour 0,00
7,30 Plage de 52 semaines 16,8793
Cap du marché
Clôture Veille
9,75
Ouverture
-
Dernière Transaction
100
@
9.74
(formt)
Dernière heure de transaction
10:12:48
Volume financier
-
VWAP
-
Volume moyen (3 m)
373 187
Actions en circulation
49 417 986
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-3,80
Bénéfice par action (BPA)
-2,56
Chiffre d'affairess
-
Bénéfice net
-126,64M

À propos de KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angio... KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Dover, Delaware, USA
Fondé
-
KalVista Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker KALV. Le dernier cours de clôture d'KalVista Pharmaceuticals était de US$9,75. Au cours de la dernière année, les actions de KalVista Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 7,30 à US$ 16,8793.

KalVista Pharmaceuticals compte actuellement 49 417 986 actions en circulation. La capitalisation boursière d'KalVista Pharmaceuticals est de US$481,83 million. KalVista Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -3.80.

KALV Dernières nouvelles

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista’s board of directors granted fifty-two newly-hired employees inducement options to...

KalVista Announces Orphan Drug Designation and NDA Submission for Sebetralstat in Japan for Hereditary Angioedema

–Orphan drug designation paves the way for potential of sebetralstat to be first oral on-demand treatment for HAE in Japan– – Submission advances Company’s strategic plan to address unmet needs...

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) today announced that the compensation committee of KalVista’s board of directors granted nine newly-hired employees inducement options to purchase an...

KalVista Appoints Jeb Ledell as Chief Operating Officer

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that Jeb Ledell has joined the Company as Chief Operating Officer (COO). Mr. Ledell is an accomplished public company COO with a...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.910.18099547518.849.948.523358979.14176924CS
41.01511.63323782238.7259.947.33200938.51092353CS
12-0.88-8.2862523540510.6210.977.33731879.00077881CS
26-2.4-19.769357495912.1413.52257.335687210.39730153CS
52-5.46-35.921052631615.216.87937.345506712.04797318CS
156-3.35-25.592055003813.0917.3454.1234990310.58997208CS
260-6.65-40.573520439316.39454.1231967415.58015398CS

KALV - Frequently Asked Questions (FAQ)

What is the current KalVista Pharmaceuticals share price?
The current share price of KalVista Pharmaceuticals is US$ 9,74
How many KalVista Pharmaceuticals shares are in issue?
KalVista Pharmaceuticals has 49 417 986 shares in issue
What is the market cap of KalVista Pharmaceuticals?
The market capitalisation of KalVista Pharmaceuticals is USD 481,83M
What is the 1 year trading range for KalVista Pharmaceuticals share price?
KalVista Pharmaceuticals has traded in the range of US$ 7,30 to US$ 16,8793 during the past year
What is the PE ratio of KalVista Pharmaceuticals?
The price to earnings ratio of KalVista Pharmaceuticals is -3,8
What is the reporting currency for KalVista Pharmaceuticals?
KalVista Pharmaceuticals reports financial results in USD
What is the latest annual profit for KalVista Pharmaceuticals?
The latest annual profit of KalVista Pharmaceuticals is USD -126,64M
What is the registered address of KalVista Pharmaceuticals?
The registered address for KalVista Pharmaceuticals is 3500 S DUPONT HWY, DOVER, DELAWARE, 19901
What is the KalVista Pharmaceuticals website address?
The website address for KalVista Pharmaceuticals is www.kalvista.com
Which industry sector does KalVista Pharmaceuticals operate in?
KalVista Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ESCAEscalade Inc
US$ 24,60
(64,11%)
55
OPOFOld Point Financial Corporation
US$ 39,51
(58,99%)
6
TWINTwin Disc Inc
US$ 17,88
(58,93%)
172
ADSEADD TEC Energy PLC
US$ 23,39
(56,66%)
18
AFRIForafric Global PLC
US$ 14,99
(56,15%)
20
SBFGSB Finanical Group Inc
US$ 12,22
(-46,85%)
10
THRYThryv Holdings Inc
US$ 10,01
(-46,01%)
4
AURAAura Biosciences Inc
US$ 5,01
(-37,38%)
4
LSBKLake Shore Bancorp Inc
US$ 11,01
(-30,23%)
1
INBXInhibrx Biosciences Inc
US$ 9,01
(-30,21%)
30
SXTP60 Degrees Pharmaceuticals Inc
US$ 0,82
(37,36%)
23,37M
CYNCYNGN Inc
US$ 0,08
(12,68%)
20,1M
UPCUniverse Pharmaceuticals Inc
US$ 0,3145
(16,52%)
19,03M
ASSTAsset Entities Inc
US$ 0,70
(27,43%)
9,06M
SFHGSamfine Creation Holdings Group Ltd
US$ 1,475
(47,50%)
8,16M
Aucune Discussion Trouvée
Ajouter une Discussion